BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22995621)

  • 1. Substituted thiazoles VII. Synthesis and antitumor activity of certain 2-(substituted amino)-4-phenyl-1,3-thiazole analogs.
    Hassan GS; El-Messery SM; Al-Omary FA; El-Subbagh HI
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6318-23. PubMed ID: 22995621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted thiazoles VI. Synthesis and antitumor activity of new 2-acetamido- and 2 or 3-propanamido-thiazole analogs.
    El-Messery SM; Hassan GS; Al-Omary FA; El-Subbagh HI
    Eur J Med Chem; 2012 Aug; 54():615-25. PubMed ID: 22743242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues.
    Al-Omary FA; Hassan GS; El-Messery SM; El-Subbagh HI
    Eur J Med Chem; 2012 Jan; 47(1):65-72. PubMed ID: 22056277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor evaluation of new polysubstituted thiazole and derived thiazolo[4, 5-d]pyrimidine systems.
    Fahmy HT; Rostom SA; Bekhit AA
    Arch Pharm (Weinheim); 2002 May; 335(5):213-22. PubMed ID: 12210778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH; El-Gamal MI; Lee YS; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
    Rostom SA
    Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
    Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
    Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
    Al-Saadi MS; Rostom SA; Faidallah HM
    Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues.
    Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L; Radin NS; Shoemaker RH
    J Med Chem; 2008 Feb; 51(4):809-16. PubMed ID: 18251494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.
    Al-Obaid AM; Abdel-Hamide SG; El-Kashef HA; Abdel-Aziz AA; El-Azab AS; Al-Khamees HA; El-Subbagh HI
    Eur J Med Chem; 2009 Jun; 44(6):2379-91. PubMed ID: 18950904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
    Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G
    J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 1,3,4-heterodiazole analogues: synthesis and in-vitro antitumor activity.
    Taher AT; Georgey HH; El-Subbagh HI
    Eur J Med Chem; 2012 Jan; 47(1):445-51. PubMed ID: 22119151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives.
    Cai J; Zhang S; Zheng M; Wu X; Chen J; Ji M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):806-10. PubMed ID: 22217877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel amidino substituted 2-phenylbenzothiazoles: synthesis, antitumor evaluation in vitro and acute toxicity testing in vivo.
    Racané L; Kralj M; Suman L; Stojković R; Tralić-Kulenović V; Karminski-Zamola G
    Bioorg Med Chem; 2010 Feb; 18(3):1038-44. PubMed ID: 20060306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.
    Liang YK; Yue ZZ; Li JX; Tan C; Miao ZH; Tan WF; Yang CH
    Eur J Med Chem; 2014 Sep; 84():505-15. PubMed ID: 25050882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro anticancer evaluation and in silico studies of novel imidazo[2,1-b]thiazole derivatives bearing pyrazole moieties.
    Ali AR; El-Bendary ER; Ghaly MA; Shehata IA
    Eur J Med Chem; 2014 Mar; 75():492-500. PubMed ID: 24576591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
    Al-Saadi MS; Faidallah HM; Rostom SA
    Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles.
    Bondock S; Adel S; Etman HA; Badria FA
    Eur J Med Chem; 2012 Feb; 48():192-9. PubMed ID: 22204901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents.
    Rostom SA
    Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
    Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
    Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.